Company Overview

Development Stage

About the Company

苏州药明博锐生物科技有限公司是由药明康德和北京大学化学院共同成立的创新型核药开发公司,目前在上海和北京设有运营和商务中心。药明博锐依托北大丰富的人才、资质和医院资源以及药明康德一体化研发服务的能力,致力于打造中国创新型核药的开发和转化平台。
我们的愿景:成为国际一流的核医药创新技术开发和转化平台。
我们的使命:聚焦精准肿瘤诊疗,造福全球病患。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (8 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Down 67%
  • 2024: Down 25%
  • 2023: Up 100%
  • 2022: Down 80%
Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Campus Recruitment & Advanced Degree Talent Demand
Master's 1 Doctorate 2
Note: How fast is hiring at 苏州博锐创合医药有限公司 growing? 2025: 2 openings (down 67%), 2024: 6 openings (down 25%), 2023: 8 openings (up 100%), 2022: 4 openings (down 80%), 2021: 20 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 75%
  • 2024: Up 33%
  • 2023: Up 50%
Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 苏州博锐创合医药有限公司 growing? Master's recruitment over the years: 2025: 1 openings (down 75%), 2024: 4 openings (up 33%), 2023: 3 openings (up 50%), 2022: 2 openings.

Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Doctoral Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 苏州博锐创合医药有限公司 growing? Doctorate recruitment over the years: 2026: 2 openings (up 300%), 2024: 2 openings (up 33%).

— What Are the Salaries Like? (13 records)

Manage
salary range: 15K - 50K, 69.3% of roles pay ¥20-50K
Note: salary statistics are based on 13 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 苏州博锐创合医药有限公司?69.3% of positions earn 20-50K, Undergraduate salary: ¥。医疗卫生/美容保健类 average salary ¥28.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 医疗卫生/美容保健类
    69.2% of total 69.2%
  • 生物/制药/化工/环保类
    53.8% of total 53.8%
  • 经营管理类
    38.5% of total 38.5%
  • 销售类
    23.1% of total 23.1%

Education

  • 本科
    53.8% of total 53.8%
  • 硕士
    30.8% of total 30.8%
  • 博士
    15.4% of total 15.4%

Experience

  • 3-5年
    61.5% of total 61.5%
  • 5-10年
    30.8% of total 30.8%
  • 1-3年
    7.7% of total 7.7%
View Detailed Analysis

What does 苏州博锐创合医药有限公司 require? Who is 苏州博锐创合医药有限公司 hiring? recruitment: 医疗卫生/美容保健类占比最多占69.2%,其次是生物/制药/化工/环保类占53.8%. What education can get in at ? 本科占比最多占53.8%,其次是硕士占30.8%. High education required at ? 硕士占30.8%,博士占15.4%. Work experience required at ? 3-5年占比最多占61.5%,其次是5-10年占30.8%. Where are the job locations at ? 上海占比最多占61.5%,其次是苏州占38.5%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 1,468.8479万(元)
Legal Representative: 单波
Date Established:
Credit Code: 91320581MA1XLYC96U
Registered Address: 苏州高新区永安路19号7幢

People who follow this company also follow

Competitors (Similar Companies)

房地产开发 酒店投资 实业投资 房地产
医药 药效学研究 生物制品 生物医药
“肿瘤细胞免疫治疗技术及产品研发商”
生物医药 医用耗材 微球 微创介入
“致力于用重组蛋白放射性药物进行肿瘤诊疗的新药研发公司”
医药 新药研发 CRO 医药CRO
航空发动机 航天器 民航 航天飞行器
制药/药业 蛋白质工程 生物制品 生物制药
生物制药 疫苗 单克隆抗体药物 抗体药
“National Innovative Demonstration Enterprise for Pharmaceutical Distri”
“Committed to the independent R&D, production, and sales of innovative ”
生命科学 基因检测 诊断试剂 试剂
飞机制造 碳纤维复合材料 装备制造 电气
生命科学 生物制药 疫苗 基因治疗

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates